Global Insulin Glargine Market Data Survey Report 2025
- HEY1469375
- 88 Pages
- August 2017
- Diagnostic and Biotech
Insulin glargine, marketed under the names Lantus among others, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. It consists of microcrystals that slowly release insulin, giving a long duration of action of 18 to 26 hours, with a "peakless" profile (according to the insulin glargine package insert).
The global Insulin Glargine market will reach xxx Million USD in 2017 with CAGR xx% from 2018-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers (manufacturing sites, capacity and production, product specifications etc.)
Average market price by SUK
Major applications
Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:
Sanofi-Aventis
Ganlee
Biocon
Major applications as follows:
Treat type 1 diabetes
Treat type 2 diabetes
Regional market size, production data and export & import:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
1 Global Market Overview
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of Application
1.1.4 Scope of Regions/Countries
1.2 Global Market Size
2 Regional Market
2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade
3 Key Manufacturers
3.1 Sanofi-Aventis
3.1.2 Company Information
3.1.2 Product Specifications
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2 Ganlee
3.2.1 Company Information
3.2.2 Product Specifications
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3 Biocon
3.3.1 Company Information
3.3.2 Product Specifications
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
4 Major Application
4.1 Treat type 1 diabetes
4.1.1 Overview
4.1.2 Treat type 1 diabetes Market Size and Forecast
4.2 Treat type 2 diabetes
4.2.1 Overview
4.2.2 Treat type 2 diabetes Market Size and Forecast
5 Market Price
5.1 Overview
5.2 Price by SUK
6 Conclusion
List Of Tables
Tab Regional Production 2011-2017 (Value)
Tab Regional Production 2011-2017 (Volume)
Tab Regional Demand and CAGR 2011-2017 (Value)
Tab Regional Demand and CAGR 2011-2017 (Volume)
Tab Regional Demand Forecast and CAGR 2018-2025 (Value)
Tab Regional Demand Forecast and CAGR 2018-2025 (Volume)
Tab Regional Export 2011-2017 (Value)
Tab Regional Export 2011-2017 (Volume)
Tab Regional Import 2011-2017 (Value)
Tab Regional Import 2011-2017 (Volume)
Tab Sales Revenue, Volume, Price, Cost and Margin of Sanofi-Aventis
Tab Sales Revenue, Volume, Price, Cost and Margin of Ganlee
Tab Sales Revenue, Volume, Price, Cost and Margin of Biocon
Tab Market Price by Region
Tab Market Price by Manufacturers
Tab Market Price by Application
Tab Price by SUK (Popular Goods on the Market)
List Of Figures
Fig Global Insulin Glargine Market Size and CAGR 2011-2017 (Value)
Fig Global Insulin Glargine Market Size and CAGR 2011-2017 (Volume)
Fig Global Insulin Glargine Market Forecast and CAGR 2018-2025 (Value)
Fig Global Insulin Glargine Market Forecast and CAGR 2018-2025 (Volume)
Fig Treat type 1 diabetes Market Size and CAGR 2011-2017 (Value)
Fig Treat type 1 diabetes Market Size and CAGR 2011-2017 (Volume)
Fig Treat type 1 diabetes Market Forecast and CAGR 2018-2025 (Value)
Fig Treat type 1 diabetes Market Forecast and CAGR 2018-2025 (Volume)
Fig Treat type 2 diabetes Market Size and CAGR 2011-2017 (Value)
Fig Treat type 2 diabetes Market Size and CAGR 2011-2017 (Volume)
Fig Treat type 2 diabetes Market Forecast and CAGR 2018-2025 (Value)
Fig Treat type 2 diabetes Market Forecast and CAGR 2018-2025 (Volume)
Fig Global Market Price 2011-2017
Fig Global Market Price 2018-2025
Similar Reports
Biomaterials are materials of either synthetic or natural origin that are used for interaction with biological systems for medical purposes such as treating or repairing damage tissues. They are used in joint replacements, plastic surgeries, drug delivery devi...
- Publish Date: September 1, 2016
- $5370
The global DNA sequencing market was estimated to be $6,243 million in 2017 and is projected to reach $25,470 million in 2025 growing with a CAGR of 19% from 2018 to 2025. DNA sequencing is a type of technology in which several DNA strands can be sequenced through massive parallelization. The DNA sequencing contains both Sanger’s method of sequencing and non-Sanger’s methods of sequencing. ...
- Publish Date: May 24, 2017
- $5370
Patients with serious nervous system injuries or strokes often require lifelong assistance, which burdens patients, their families, and society. Innovative, paradigm shifting strategies are required to develop treatments for neurological injury. Early dia...
- Publish Date: May 24, 2017
- $5370
